{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:04:34Z","timestamp":1785683074582,"version":"3.56.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Mycosis fungoides (MF) and Sezary syndrome (SS) are common entities among primary cutaneous lymphomas. Large cell transformation is challenging for diagnosis and therapy. Molecular mechanisms by which these lymphomas undergo this transformation are poorly defined. We studied the immunohistochemical status of p53 in these entities and assessed whether p53 expression could be a useful tool for diagnosis and assessment of transformation. We extracted patients with transformed and untransformed SS or MF from the French Study Group on Cutaneous Lymphoma database between 2014 and 2021, followed in the Rennes University Hospital. An immunohistochemical study of p53 expression was performed on the biopsies sampled as part of routine care. We compared p53 overexpression in the different groups. We included 25 patients with MF, 7 patients with transformed MF (T-MF), 11 patients with SS, and 5 patients with transformed SS (T-SS). Using a cut-off set at 30% expression of neoplastic cells, we noted an overexpression of p53 in T-MF and T-SS compared with nontransformed forms (47% vs. 12%, respectively, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01) and in MF compared with SS (23% vs. 7%, respectively, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). Overexpression of p53 with a cut-off at 30% therefore seems to be a discriminating tool in the differential diagnosis of MF\/SS versus their transformed forms as well as the differential diagnosis between MF and SS.<\/jats:p>","DOI":"10.1097\/dad.0000000000002898","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:50:59Z","timestamp":1733943059000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed Forms"],"prefix":"10.1097","volume":"47","author":[{"given":"Anna","family":"Courtois","sequence":"first","affiliation":[{"name":"Department of Pathology, Rennes University Hospital, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-3396","authenticated-orcid":false,"given":"Pierre","family":"Allaume","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rennes University Hospital, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Raby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rennes University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Pastoret","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rennes University Hospital, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Droitcourt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rennes University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Le Naour\u00e8s","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rennes University Hospital, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Adamski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rennes University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rennes University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Le Gall","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rennes University Hospital, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne-Florence","family":"Kammerer-Jacquet","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rennes University Hospital, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.19829","article-title":"Epidemiology of cutaneous lymphoma","volume":"184","author":"Vermeer","year":"2021","journal-title":"Br J Dermatol."},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1590\/S0365-05962012000600001","article-title":"Mycosis fungoides and S\u00e9zary syndrome: clinical, histopathological and immunohistochemical review and update","volume":"87","author":"Yamashita","year":"2012","journal-title":"Bras Dermatol."},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2014update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"R5-20250124","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.17258","article-title":"The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients","volume":"181","author":"Scarisbrick","year":"2019","journal-title":"Br J Dermatol."},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in s\u00e9zary syndrome and mycosis fungoides","volume":"148","author":"\u00c7etin\u00f6zman","year":"2012","journal-title":"Arch Dermatol."},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1200\/JCO.1995.13.7.1751","article-title":"Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor","volume":"13","author":"Wolfe","year":"1995","journal-title":"J Clin Oncol"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jid.2018.06.176","article-title":"An integrated data resource for genomic analysis of cutaneous T-cell lymphoma","volume":"138","author":"Chang","year":"2018","journal-title":"J Invest Dermatol."},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","article-title":"Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in S\u00e9zary syndrome and mycosis fungoides","volume":"147","author":"Mao","year":"2002","journal-title":"Br J Dermatol."},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1747.1999.00507.x","article-title":"Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas","volume":"112","author":"McGregor","year":"1999","journal-title":"J Invest Dermatol."},{"key":"R14-20250124","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet."},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with S\u00e9zary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fmed.2016.00051","article-title":"TP53 gene status affects survival in advanced mycosis fungoides","volume":"3","author":"Wooler","year":"2016","journal-title":"Front Med."},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1051\/medsci\/2002185577","article-title":"Activation et modifications post-traductionnelles de p53 apr\u00e8s dommage de l'ADN","volume":"18","author":"Leblanc","year":"2002","journal-title":"M\u00e9decine\/Sciences"},{"key":"R18-20250124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.2000.tb06705.x","article-title":"The p53 tumor suppressor gene: from molecular biology to clinical investigation","volume":"910","author":"Soussi","year":"2000","journal-title":"Ann New York Acad Sci."},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cup.13375","article-title":"Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation","volume":"46","author":"Raghavan","year":"2019","journal-title":"J Cutan Pathol."},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1523-1747.1998.00167.x","article-title":"Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression","volume":"110","author":"Li","year":"1998","journal-title":"J Invest Dermatol"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"e0173171","DOI":"10.1371\/journal.pone.0173171","article-title":"TP53 alterations in primary and secondary S\u00e9zary syndrome: a diagnostic tool for the assessment of malignancy in patients with erythroderma","volume":"12","author":"Gros","year":"2017","journal-title":"PLos One"},{"key":"R24-20250124","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"S\u00e9zary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"R25-20250124","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","journal-title":"Blood"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:00:42Z","timestamp":1737727242000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002898","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}